SCHEMBL20111914

SCHEMBL20111914

CCNCCNCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14433993 0.85 CYP2C19 (0.60)
SCHEMBL308579 0.82
SCHEMBL80292 0.82
SCHEMBL10874057 0.80 CA12 (0.62)
SCHEMBL28706188 0.78
Hydrochloric Acid SCHEMBL13859051 0.78 CYP2C19 (0.60)
SCHEMBL30612397 0.78 CYP2C19 (0.71)
SCHEMBL2893263 0.78 CYP2C19 (0.71)
Iodide SCHEMBL7119508 0.78 CYP2C19 (0.60)
SCHEMBL11321305 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018081530-A1 COMPOSITIONS AND METHODS FOR TREATING EZH2-MEDIATED CANCER ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2018-05-03 WO disclosed